Gemcitabine-Loaded PLGA Ureteral Stents via Sacrificial Electrospinning: Release Kinetics and Anti-Tumor Mechanism
Biomacromolecules · 10.08.2026 · 27 (8) · 5223-5238
DOI: 10.1021/acs.biomac.6c00438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 14.07.2026. Verfasst von Jinlong Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Textile Engineering, Taiyuan University of Technology, Taiyuan030024, China. Hauptthemen laut MEDLINE: Polylactic Acid-Polyglycolic Acid Copolymer, Deoxycytidine, Drug-Eluting Stents. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Shanxi Scholarship Council of China, Taiyuan University of Technology, Shanxi Provincial Key Research and Development Project.
Abstract (Originalsprache)
The rational design of drug-eluting polymeric implants requires a fundamental understanding of macromolecular structure, degradation, and transport kinetics. Herein, we report the structure–property-function relationships of a gemcitabine-loaded poly(lactic-co-glycolic acid) (PLGA) nanofibrous matrix, engineered into a precise tubular architecture via a modified sacrificial template electrospinning strategy. Physicochemical characterization elucidated excellent drug-polymer compatibility, enabling the homogeneous, amorphous dispersion of gemcitabine within the PLGA network. Macroscopically, the engineered matrix overcomes traditional electrospinning defects, retaining essential mechanical robustness (specifically radial compression recovery) during its functional window. Crucially, the polymeric network exhibits a highly regulated, biphasic release profile extending over 30 days, which is fundamentally governed by a coupled Fickian diffusion and bulk polymer erosion mechanism (anomalous transport, n = 0.53). As a biological validation of this tailored macromolecular design, the construct was evaluated in a subcutaneous xenograft model of upper tract urothelial carcinoma (UTUC). The spatiotemporally controlled release translated into a potent 70.5% tumor inhibition rate with negligible systemic toxicity. Immunohistochemical analysis confirmed that the locally delivered drug retained its bioactivity, effectively triggering a specific P53/P21/Cyclin B-mediated G2/M phase cell cycle arrest. Consequently, this study establishes a robust fundamental paradigm for designing functionalized polymeric architectures tailored for localized cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Textile Engineering, Taiyuan University of Technology, Taiyuan030024, China.
- Department of Urology, First Hospital of Shanxi Medical University, Taiyuan030001, China.
ORCID-Profile: Jinlong Zhu, Man Zhang, Lu Jia
Förderung
- Shanxi Scholarship Council of China
- Taiyuan University of Technology
- Shanxi Provincial Key Research and Development Project
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Zhu, J., Liu, S., Ji, M., Yan, P., Sun, R., Li, X., Yao, Y., Wu, G., Zhang, M., Jia, L., & Zhang, Y. (2026). Gemcitabine-Loaded PLGA Ureteral Stents via Sacrificial Electrospinning: Release Kinetics and Anti-Tumor Mechanism. Biomacromolecules, 27(8), 5223-5238. https://doi.org/10.1021/acs.biomac.6c00438
Vancouver
Zhu J, Liu S, Ji M, Yan P, Sun R, Li X, et al. Gemcitabine-Loaded PLGA Ureteral Stents via Sacrificial Electrospinning: Release Kinetics and Anti-Tumor Mechanism. Biomacromolecules. 2026;27(8):5223-5238. doi:10.1021/acs.biomac.6c00438
BibTeX
@article{Zhu2026,
author = {Zhu, Jinlong and Liu, Shuqiang and Ji, Mengjiao and Yan, Pengyu and Sun, Rui and Li, Xinyi and Yao, Yanan and Wu, Gaihong and Zhang, Man and Jia, Lu and Zhang, Yujing},
title = {Gemcitabine-Loaded PLGA Ureteral Stents via Sacrificial Electrospinning: Release Kinetics and Anti-Tumor Mechanism},
journal = {Biomacromolecules},
year = {2026},
volume = {27},
number = {8},
pages = {5223--5238},
doi = {10.1021/acs.biomac.6c00438}
}
EUVIMED